1. Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery Disease
- Author
-
Andrew E. Arai, Jeanette Schulz-Menger, Daniel Berman, Heiko Mahrholdt, Yuchi Han, W. Patricia Bandettini, Matthias Gutberlet, Arun Abraham, Pamela K. Woodard, Joseph B. Selvanayagam, Gerry P. McCann, Christian Hamilton-Craig, U. Joseph Schoepf, Ru San Tan, Christopher M. Kramer, Matthias G. Friedrich, Daniel Haverstock, Zheyu Liu, Guenther Brueggenwerth, Claudia Bacher-Stier, Marta Santiuste, Dudley J. Pennell, Dudley Pennell, Ulrich Kramer, Giso von der Recke, Kai Nassenstein, Christoph Tillmanns, Matthias Taupitz, Gregor Pache, Oliver Mohrs, Joachim Lotz, Sung-Min Ko, Ki Seok Choo, Yon Mi Sung, Joon-Won Kang, Stefano Muzzarelli, Uma Valeti, Gerry McCann, Sukumaran Binukrishnam, Pierre Croisille, Alexis Jacquier, Brett Cowan, Andrew Arai, Dipan Shah, Pamela Woodard, Ryan Avery, Joseph Schoepf, James Carr, Christopher Kramer, Scott Flamm, Mukesh Harsinghani, Stamitios Lerakis, Raymond Kim, Subha Raman, Francois Marcotte, Ali Islam, Matthias Friedrich, Joseph Selvanayagam, Woon Kit Chong, Li San Lynette Teo, and British Heart Foundation
- Subjects
Male ,Cardiac & Cardiovascular Systems ,MULTICENTER ,Contrast Media ,CAD ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,ANGIOGRAPHY ,Gadobutrol ,Coronary artery disease ,0302 clinical medicine ,FRACTIONAL FLOW RESERVE ,Prevalence ,030212 general & internal medicine ,CMR ,1102 Cardiorespiratory Medicine and Haematology ,medicine.diagnostic_test ,Area under the curve ,Middle Aged ,EMISSION-COMPUTED-TOMOGRAPHY ,Magnetic Resonance Imaging ,myocardial infarction ,Cardiology ,HEART-FAILURE ,Female ,GUIDED PCI ,Cardiology and Cardiovascular Medicine ,Life Sciences & Biomedicine ,gadobutrol ,Perfusion ,myocardial perfusion ,medicine.drug ,medicine.medical_specialty ,MYOCARDIAL-PERFUSION MRI ,GadaCAD Investigators ,MEDICAL THERAPY ,1117 Public Health and Health Services ,03 medical and health sciences ,Cardiac magnetic resonance imaging ,Internal medicine ,Organometallic Compounds ,medicine ,Humans ,DIAGNOSTIC-ACCURACY ,cardiovascular diseases ,Aged ,Science & Technology ,business.industry ,Magnetic resonance imaging ,medicine.disease ,Cardiac Imaging Techniques ,Stenosis ,Cardiovascular System & Hematology ,Cardiovascular and Metabolic Diseases ,Cardiovascular System & Cardiology ,FOLLOW-UP ,business - Abstract
Background Gadolinium-based contrast agents were not approved in the United States for detecting coronary artery disease (CAD) prior to the current studies. Objectives The purpose of this study was to determine the sensitivity and specificity of gadobutrol for detection of CAD by assessing myocardial perfusion and late gadolinium enhancement (LGE) imaging. Methods Two international, single-vendor, phase 3 clinical trials of near identical design, “GadaCAD1” and “GadaCAD2,” were performed. Cardiovascular magnetic resonance (CMR) included gadobutrol-enhanced first-pass vasodilator stress and rest perfusion followed by LGE imaging. CAD was defined by quantitative coronary angiography (QCA) but computed tomography coronary angiography could exclude significant CAD. Results Because the design and results for GadaCAD1 (n = 376) and GadaCAD2 (n = 388) were very similar, results were summarized as a fixed-effect meta-analysis (n = 764). The prevalence of CAD was 27.8% defined by a ≥70% QCA stenosis. For detection of a ≥70% QCA stenosis, the sensitivity of CMR was 78.9%, specificity was 86.8%, and area under the curve was 0.871. The sensitivity and specificity for multivessel CAD was 87.4% and 73.0%. For detection of a 50% QCA stenosis, sensitivity was 64.6% and specificity was 86.6%. The optimal threshold for detecting CAD was a ≥67% QCA stenosis in GadaCAD1 and ≥63% QCA stenosis in GadaCAD2. Conclusions Vasodilator stress and rest myocardial perfusion CMR and LGE imaging had high diagnostic accuracy for CAD in 2 phase 3 clinical trials. These findings supported the U .S. Food and Drug Administration approval of gadobutrol-enhanced CMR (0.1 mmol/kg) to assess myocardial perfusion and LGE in adult patients with known or suspected CAD.
- Published
- 2020